Cancer is a complex and multidimensional disease. If you or a loved one has cancer, choosing a health care team to help you win the battle may be one of the most important decisions you make. At Penn State Health St. Joseph, we care about you, your family and your fight against cancer. Our dedicated team of professionals, coordinated by board-certified oncology specialists, works together to create a personalized treatment plan, specific for you and your type of cancer. We will give you up-to-date and understandable information about your cancer and treatment. We will explain the results of diagnostic tests and provide specifics on treatment options, which could include access to national cooperative group clinical trials when appropriate, and access to treatment using state-of-the-art technologies and drug therapies.
The Radiation Oncology and Medical Oncology departments are located side by side in the Cancer Center on the Garden Level of the Penn State Health St. Joseph Medical Office Building. The facility groups the oncology specialists together to facilitate more frequent consultations and better patient coordination. With ground floor access and free parking, entrance into the Cancer Center is easy and convenient for patients and their families.
Penn State Health St. Joseph Center treats patients with hematologic (blood) and oncologic (cancer) diseases. The Medical Oncology Department, under the clinical leadership of Marc Rovito, MD, Medical Director of the Penn State Health St. Joseph Cancer Center, offers patients access to leading-edge chemotherapy, as well as targeted and biological modifier therapies. Medical Oncologists, Nurse Practitioners, and Oncology Nurses care for patients in our infusion room, which overlooks the beautiful Schuylkill Valley. During Tumor Board sessions, the oncologists interact with a multidisciplinary team of physicians–oncologists, surgeons, family doctors, pathologists, radiologists, specialists–who review specific patient cases and, together with the patient, makes recommendations for coordinated treatment. Eligible patients also are considered for appropriate pharmaceutical and national cooperative group clinical trials.